Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Anti-EGFR monoclonal antibodies can bind to the extracellular domain of EGFR in its inactive state; they compete for receptor binding by occluding the ligand-binding region, and thereby block ligand-induced EGFR tyrosine kinase activation.